Summary & Overview
HCPCS G9746: AF with Mitral Stenosis, Prosthetic Valve, or Reversible Cause
HCPCS Level II code G9746 designates patients with mitral stenosis or prosthetic heart valves, or those whose atrial fibrillation (AF) is linked to transient or reversible causes such as infection, hyperthyroidism, pregnancy, or recent cardiac surgery. Nationally, the code matters because it identifies a clinically distinct AF population where anticoagulation strategies, procedural planning, and follow-up differ from non-valvular AF populations. Proper use of G9746 supports accurate clinical classification, billing alignment, and population-level monitoring of valvular and transient-cause AF.
Key payers considered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and typical sites of service, along with what to expect in the full publication: payer coverage patterns and benchmarks, relevant policy or coding guidance updates, clinical implications for classification of AF, and common billing considerations tied to this clinical subgroup. The report does not recommend clinical actions but clarifies how G9746 is used to denote AF when mitral stenosis, prosthetic valves, or reversible causes are present and outlines areas where payers and providers commonly focus when applying this classification.
Billing Code Overview
HCPCS Level II code G9746 denotes patients with mitral stenosis or prosthetic heart valves, or patients whose atrial fibrillation (AF) has a transient or reversible cause (for example, pneumonia, hyperthyroidism, pregnancy, or recent cardiac surgery). This code is used to categorize clinical scenarios in which AF is present but is associated with specific structural valvular disease or clearly reversible precipitants.
-
Service type: Evaluation and management related to atrial fibrillation in the context of valvular heart disease or transient/reversible causes
-
Typical site of service: Inpatient hospital settings, outpatient cardiology clinics, and perioperative or post-procedural care environments
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old with a history of atrial fibrillation and a prior mechanical mitral valve replacement who presents for assessment of long-term anticoagulation and AF management. The clinical workflow begins in an outpatient cardiology clinic or anticoagulation clinic where the cardiologist or advanced practice provider reviews the patients history, valve type, rhythm documentation, and any recent transient reversible causes of AF such as pneumonia, thyrotoxicosis, or recent cardiac surgery. The team confirms indication for specialized AF counseling or management coding related to mitral stenosis or prosthetic heart valve status and documents the reversible causes if present. Typical encounters occur in the ambulatory cardiology clinic, anticoagulation clinic, or perioperative clinic following cardiac surgery; inpatient consultations for acute reversible causes (e.g., pneumonia, hyperthyroidism) may also apply. Documentation includes valve prosthesis type, confirmatory imaging or operative report, rhythm tracings or ECG, reversible cause evaluation, and the management plan (rate/rhythm strategy, anticoagulation plan). Common payors for claim adjudication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the service due to complexity of valve-related AF management or extensive counseling. |